ClinicalTrials.govpublic full text
Combination Therapy of L19IL2 and Gemcitabine in Advanced Pancreatic Cancer Patients
pancreatic cancer patients diagnosed with locally advanced or metastatic pancreatic cancer not amenable to curative surgical resection, interleukin, il2, gemcitabine, monoclonal, antibody, cytokine, tumour targeting, dose finding, fusion protein, pancreatic cancer,, l19, interventional, phase1
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗Related documents
Record · ID 843873
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.